|
03 May 2007 |
Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
|
|
03 May 2007 |
Anadys Presents Results From Its NS5b HCV Program at International Conference on Antiviral Research
|
|
03 May 2007 |
YM Biosciences Reports Aerolef(TM) Randomized Phase Iib Trial Meets Primary Endpoint In Patients With Post-Surgical Pain
|
|
02 May 2007 |
Up and down with cholesterol management
|
|
02 May 2007 |
deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
|
|
02 May 2007 |
Trigen's innovative platelet adhesion inhibitor, PR-15, successfully completes first-in-man Phase I study
|
|
02 May 2007 |
Sciele Pharma Signs Exclusive License Agreement with LifeCycle Pharma A/S To Market a New Formulation of Fenofibrate in 120 mg and 40 mg Dosage Strengths
|
|
02 May 2007 |
Acusphere Announces Positive Results from Pivotal Phase 3 Clinical Trial of Imagify(TM)
|
|
02 May 2007 |
Transport Pharmaceuticals Initiates Patient Enrollment In Phase 2 Study Of Solovir System For Herpes Labialis
|
|
02 May 2007 |
Hollis-Eden Pharmaceuticals Cleared by FDA to Initiate Phase I Clinical Trial with HE3286 in Treating Metabolic Disorders
|
|
02 May 2007 |
Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
|
|
02 May 2007 |
Lyrica Significantly Reduced Pain and Helped Patients Manage the Symptoms of Fibromyalgia, Data Show
|
|
02 May 2007 |
Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe
|
|
02 May 2007 |
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
|
|
02 May 2007 |
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
|
|
02 May 2007 |
Sirion Therapeutics Initiates Two Phase III Clinical Trials
|
|
02 May 2007 |
Optimer Pharmaceuticals Initiates Second Phase 3 Trial of OPT-80 for CDAD
|
|
02 May 2007 |
Accera, Inc. Announces Results of Phase II Study in Alzheimer's Disease at American Academy of Neurology Meeting
|
|
01 May 2007 |
Sebivo(R) (Telbivudine) Approved in European Union as a New Treatment for Chronic Hepatitis B Patients
|
|
01 May 2007 |
InSite Vision Announces FDA Approval for AzaSite(TM) Approval Triggers $19 Million Milestone Payment
|
|
01 May 2007 |
Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea
|
|
01 May 2007 |
Interim report about clinical trial of BF-200 ALA in actinic keratosis
|
|
28 Apr 2007 |
Diovan(R) achieved 40% reduction in stroke and cardiovascular events in landmark Jikei Heart Study
|
|
28 Apr 2007 |
Kyowa Hakko in-licenses ARQ 197, an anticancer agent in clinical development, from the US company ArQule.
|
|
28 Apr 2007 |
Submission of New Drug Application for Istradefylline(KW-6002), an investigational anti-Parkinson's disease drug
|
